z-logo
open-access-imgOpen Access
Ruxolitinib and Severe COVID-19
Author(s) -
Rujittika Mungmunpuntipantip,
Viroj Wiwanitkit
Publication year - 2021
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2021.0110
Subject(s) - medicine , ruxolitinib , covid-19 , virology , betacoronavirus , pandemic , coronavirus infections , intensive care medicine , outbreak , myelofibrosis , infectious disease (medical specialty) , bone marrow , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here